{"id":"W2143498161","doi":"10.1158/0008-5472.sabcs10-p2-16-06","title":"Abstract P2-16-06: Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Medicine; Taxane; Docetaxel; Internal medicine; Regimen; Chemotherapy; Clinical endpoint; Metastatic breast cancer; Oncology; Population; Chemotherapy regimen; Surgery; Progression-free survival; Anthracycline; Cancer; Breast cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001933263,0.0006713732,0.0009818503,0.0006411888,0.0003299806,0.0007491044,0.0006180117,0.0006015065,0.001859068],"category_scores_gemma":[0.001259089,0.0003030797,0.001645863,0.0005805494,0.0002167756,0.0005009123,0.0006606801,0.0007918589,0.0006202006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005219103,"about_ca_system_score_gemma":0.000468385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001077914,"about_ca_topic_score_gemma":0.002265835,"domain_scores_codex":[0.999526,0.0001372626,0.00005576351,0.0001515591,0.00007358032,0.00005581549],"domain_scores_gemma":[0.9986603,0.0002259324,0.0004134889,0.0001493971,0.0001240891,0.0004267739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08734445,0.00154962,0.8785207,0.0003430987,0.004535689,0.0003415646,0.000113452,0.001237244,0.003653937,0.00004488439,0.003700024,0.01861529],"study_design_scores_gemma":[0.006019067,0.008235782,0.9804586,0.00002931118,0.00154609,0.0006606,0.00005036183,0.0005240176,0.000631521,0.00004390924,0.001776135,0.00002463306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911252,0.0008357578,0.0001686797,0.00005609932,0.00001766786,0.0001294729,0.006482858,0.00001836526,0.001165789],"genre_scores_gemma":[0.9774161,0.0002474479,0.0002882324,0.0001074862,0.00005715959,0.0001964184,0.02070127,0.00001592423,0.000969849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001933263,"threshold_uncertainty_score":0.01022416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1836768031969175,"score_gpt":0.4780208092411699,"score_spread":0.2943440060442524,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}